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Abstract 
The mitochondrial ADP/ATP carrier catalyses the equimolar exchange of adenosine di- and tri-
phosphates. It operates by an alternating access mechanism in which a single substrate-binding site 
is made available either to the mitochondrial matrix or the intermembrane space through 
conformational changes. These changes are prevented in the absence of substrate by a large energy 
barrier due to the need for sequential disruption and formation of a matrix and cytoplasmic salt 
bridge network that are located on either side of the central cavity. In analogy to enzyme catalysis, 
substrate lowers the energy barrier by binding tighter in the intermediate state. Here we provide an 
in-silico kinetic model that captures the free energy profile of these conformational changes and 
treats the carrier as a nanomachine moving stochastically from the matrix to cytoplasmic 
conformation under the influence of thermal energy. The model reproduces the dependency of 
experimentally determined kcat and KM values on the cytoplasmic network strength with good 
quantitative accuracy, implying that it captures the transport mechanism and can provide a 
framework to understand the structure-function relationships of this class of transporter. The results 
show that maximum transport occurs when the interaction energies of the cytoplasmic network, 
matrix network and substrate binding are approximately equal such that the energy barrier is 
minimized. Consequently, the model predicts that there will be other interactions in addition to 
those of the cytoplasmic network that stabilise the matrix conformation of the ADP/ATP carrier.  
 
Key words: adenine nucleotide translocase; adenine nucleotide translocator; substrate exchange; 
mathematical model; Boltzmann distribution; transport protein 
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Highlights 
1. A Markov state model of molecular kinetics is developed for the ADP/ATP carrier. 
2. Captures the free energy profile of the conformational changes of transport. 
3. Validated against kinetic measurements from a set of mutant carriers. 
4. Establishes how structure shapes the free energy profile, which defines function 
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Graphical Abstract 
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Introduction 
In the functioning mitochondrion the mitochondrial ADP/ATP carrier forms part of the 
mitochondrial ATP circuit, importing cytosolic ADP into the matrix and exporting ATP 
synthesized by the FoF1 ATP synthase into the intermembrane space, which is confluent with the 
cytosol [1], see [2] for a recent review. The protein cycles between matrix and cytoplasmic 
conformations in which the substrates can bind reversibly from the mitochondrial matrix and the 
intermembrane space, respectively. The specific inhibitors atractyloside and carboxyatractyloside 
lock the transporter in the cytoplasmic conformation, whereas bongkrekic acid locks the carrier in 
the matrix conformation [3-5]. As with all mitochondrial carrier proteins, the ADP/ATP carrier 
consists of three homologous ~100 amino acid repeat domains [6-7], each composed of two 
transmembrane α-helices separated by a matrix loop and small α-helix [8]. The atomic structures of 
the bovine and yeast ADP/ATP carriers inhibited by carboxyatractyloside show that the three repeat 
domains form a six α-helical barrel around a central cavity that is open to the intermembrane space 
[8-9]. By considering conservation of amino acids as well as distance and chemical constraints, and 
by analysis of the pseudo-symmetry of mitochondrial carriers, a single substrate-binding site was 
identified in the centre of the cavity [10-12]. ADP also binds to this site in labelling studies [13] 
and molecular dynamics simulations [14-16]. 
Strict exchange of nucleotides is essential because the presence of the membrane potential (positive 
outside) would lead to their depletion from the matrix due to their negative charge if uniport 
activity were to occur. Furthermore, exchange obligates the carrier to act as an energy-transducing 
protein due to the charge difference between ATP
4−
 and ADP
3−
 and hence maintains the cytosolic 
ATP/ADP ratio higher than the mitochondrial ATP/ADP ratio [17]. Structural evidence supports an 
alternating access mechanism of substrate exchange by the carrier [9, 12], equivalent to a ping-
pong mechanism, where one substrate is transported but leaves the substrate binding site before a 
counter-substrate binds for transport in the opposite direction. Importantly, for strict exchange in 
this manner, the change between matrix and cytoplasmic 
conformations should not occur in the absence of bound 
substrate. Klingenberg [18] suggested that there is a 
large energy barrier for conversion between the matrix 
and cytoplasmic conformations and that, in analogy to 
enzyme catalysis, the presence of bound substrate 
lowers this barrier by tighter binding in the intermediate 
conformation, but the molecular nature of this barrier 
has not been addressed. 
The odd-numbered transmembrane α-helices (H1, H3 
and H5) of the carrier each contain the signature motif 
of the carrier family, Px[DE]xx[RK] [6, 19], which 
forms an inter-domain salt bridge network on the matrix 
side of the protein, closing access of the substrate 
binding site to the matrix when the carrier is in the 
cytoplasmic conformation [8]. By using sequence 
analysis [20] a second motif was discovered on the 
even-numbered transmembrane α-helices with the 
consensus [FY][DE]xx[RK] and it has been shown that 
the charged residues of this motif form an inter-domain 
salt bridge network on the cytoplasmic side, closing 
access to the substrate binding site to the intermembrane 
space when the carrier is in the matrix-facing 
conformation [9, 21]. The conformational change 
allowing the sequential breaking and formation of these 
 
Figure 1. Proposed energy profile for the 
mitochondrial ADP/ATP carrier. From the 
unbound intermediate conformation, the free 
energy of the carrier is lowered by formation of 
the bonds of the matrix and cytoplasmic network 
on movement to the cytoplasmic or matrix 
conformation. Substrate can only bind from the 
matrix or cytoplasmic conformation but the 
binding energy is greater in the intermediate 
conformation lowering the energy barrier for 
transport. 
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5 
networks probably involves movement around the conserved pralines and glycines [22]. 
The sequential breaking and formation of the bonds of the matrix and cytoplasmic networks 
provides an energy barrier for the change between cytoplasmic and matrix conformations. Figure 1 
shows a plausible energy profile for the carrier based on this mechanism. In the absence of 
substrate, the changes between cytoplasmic and intermediate conformations would break the bonds 
of the matrix salt-bridge network, raising the standard chemical potential of the carrier to a 
maximum in the intermediate conformation. Further changes towards the matrix conformation 
would form the bonds of the cytoplasmic salt-bridge network, lowering the standard chemical 
potential, and making the substrate-binding site accessible from the matrix side. Binding of 
substrate in the cytoplasmic conformation lowers the standard chemical potential of the carrier due 
to the energy of the bonds (ΔEb) formed between the carrier and the substrate. The conformational 
changes would then allow the substrate to bind tighter, increasing the binding energy until it was at 
a maximum in the intermediate-state. Further conformational changes towards the matrix-state 
would weaken the substrate-carrier bonds and lead to a decrease in the binding energy. Thus tighter 
binding of the substrate in the intermediate conformation would lower the energy barrier between 
cytoplasmic and matrix conformations. 
The magnitude of the energy barrier between cytoplasmic and intermediate conformations, and 
between matrix and intermediate conformations, will depend on the total number and individual 
strengths of the salt bridges in the matrix and cytoplasmic networks, respectively. The matrix 
network of the wild type carrier contains three salt bridges, but is further strengthened by a 
glutamine residue that forms a brace between residues of the salt bridge linking domains one and 
three [9]. This gives the matrix network a strength equivalent to 3.5 salt bridges, assuming that a 
hydrogen bond has about half the strength of a salt bridge [12]. There is no structure of the matrix 
state, but on the basis of sequence information, the cytoplasmic network of fungal carriers contains 
two salt bridges and a hydrogen bond, giving it a relative strength of 2.5, whereas that of the 
mammalian carriers contains three salt bridges, providing an overall strength of 3.0. Recently, we 
have generated a set of mutants in the fungal ADP/ATP carrier in which the number of salt bridges, 
and hence interaction energy, of the cytoplasmic network was increased and decreased. We have 
shown that the stability of the carrier in detergent is independent of the cytosolic network strength 
when the carrier is locked in the cytoplasmic conformation with carboxyatractyloside, but is 
proportional to the network strength when the carrier is locked in the matrix conformation with 
bongkrekic acid, demonstrating that the cytoplasmic network is only interacting in the matrix 
conformation [21]. 
Previous mathematical models have treated the intermediate conformation as a transition state 
between matrix and cytoplasmic conformations [23-25] and did not treat the carrier as a 
nanomachine that moves stochastically and continuously from the matrix to cytoplasmic 
conformation under the influence of thermal energy [26]. In these models the rate constants for this 
conformational change, which determines the transport rate, must be fitted from experimental data. 
Here we have developed a Markov model of molecular kinetics [27] that captures the stochastic 
motion of the carrier and, with the addition of a substrate binding site, can predict transport rates 
based on the free energy profile of the conformational changes that occur, which in turn is 
determined by the strength of substrate binding and the two salt bridge networks. The model is 
validated against kinetic measurements made with a set of mutant carriers with altered cytoplasmic 
network strengths and is then used to establish how the free energy profile, which is determined by 
the structure, defines the function of the carrier. 
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Methods 
The continuous change between matrix and cytoplasmic conformations can be considered as a 
diffusion along a one-dimensional track by random walk governed by thermal energy [26] and was 
modelled as 21 discrete steps labelled 10c  to 10  where 10c  is the cytoplasmic 
conformation, 0c  is the intermediate conformation and 10c  is the matrix conformation. The 
model includes a single substrate binding site that could be either empty or have a nucleotide 
bound, thus the state <c,s> of the system is fully described by the conformation, c, and the 
occupancy, s, of the substrate binding site. The kinetic model is summarized in figure 2 where the 
horizontal lines represent the states and bi-arrows represent transitions, analogous to chemical 
reactions, which connect pairs of states with forward and reverse rate constants. Binding of a 
substrate from the respective compartment was only allowed from the cytoplasmic and matrix 
conformation with rate constants sceck ,,   and ecsck ,,   where 10c  or 10 , e represents the 
unbound carrier and s represents the bound nucleotide. The conformational changes were modelled 
by connecting neighbouring conformations c and c+1 with forward and reverse rate constants, 
scsck ,1,   and scsck ,,1  which depend on the substrate, s, bound (s can be either none or a 
nucleotide). The total number of states in the system is 21(N+1) and the number of reactions is 
20(N+1)+2N were N is the number of substrates that can bind to the carrier in a mutually exclusive 
way. Only a single chemical species, ADP, was considered as the model is compared to published 
experimental data in which radio-labelled cytosolic ADP was exchanged for unlabelled matrix 
ADP [21]. This data was modelled using two substrates (N=2), ‘labelled’ and ‘unlabelled’ ADP, so 
that substrate that bound from one side and then was released to the same side could be 
distinguished from substrate that was transported, i.e. bound from one side and released to the other 
side. The same rate constants were used throughout for both labelled and unlabelled substrate, as 
they are considered identical chemical species. 
The standard free energy change for the enzyme with substrate s bound between neighbouring 
conformations c and c+1, 
0
,1, scscG  , is related to the rate constants and standard chemical 
potentials of states <c,s> and <c+1,s>, 
0
,sc  and
0
,1 sc , respectively, by 
 
Figure 2. A summary of the kinetic model. Horizontal lines represent states and bidirectional arrows represent reactions. 
The zero on the energy scale is set for the carrier with no substrate bound and the networks disengaged. The chemical 
potential of the unbound cytoplasmic conformation (C) is lowered by formation of the matrix network with free energy 
ΔEM. Likewise, the matrix conformation (M) is lowered by formation of the cytoplasmic network with free energy ΔEC. 
The bound states are further lowered by the free energy of binding ΔEB in the cytoplasmic and matrix conformation in 
the absence of the induced fit and the conformation-dependent induced-fit binding energy ΔES such that the total binding 
energy is in a given conformation is ΔEB+ΔES. 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
 
 
7 
 
0
,
0
,1,,1
,1,
0
,1, Ln scscscsc
scsc
Bscsc
k
k
TkG  








 

  
Equation 1 
Where kB is the Boltzmann’s constant and T is the temperature in Kelvin. Free energies are 
expressed in mV (10.36 mV=1 KJ/mole) so that the thermodynamic efficiency of the carrier can 
ultimately be compared with that of the electron transport chain [28]. The modelling assumed a 
temperature of 37 °C at which kBT has a value of 26.7 mV.  
The standard chemical potential of the carrier in the c
th
 conformation with substrate, s, bound was 
assumed to be the sum of the free energy of formation of the matrix and cytoplasmic networks and 
substrate binding energy, 
 sc
B
c
C
c
Msc EEE
,0
,   
Equation 2 
Where cME  and 
c
CE  are the free energy of the formation of the bonds of the matrix and 
cytoplasmic networks in the c
th
 conformation and are independent of substrate bound, respectively, 
and scBE
,  is the free energy of substrate, s, binding in the c
th
 conformation, which is zero when no 
substrate is bound. To ensure the thermodynamic fidelity of the model, the rates were calculated 
from the standard free energy change of the reaction step by splitting it equally between the 
forward and reverse rates, 
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Equation 3 
where kc is the rate of the conformational change at ΔG
0
=0. The large number of discrete 
conformations ensured that the ΔG0 between any two neighbouring conformations was small so that 
the forward and reverse rates were similar to kc. The dependence of the interaction energy on 
conformational state was chosen to be Gaussian such that: 
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Equation 4 
where BE is the substrate binding energy in the cytoplasmic and matrix conformations in the 
absence of the induced-fit, ΔEC, ΔEM and ΔES are scaling factors describing the strength of the 
cytoplasmic network, the matrix network and the induced-fit substrate binding energy, respectively. 
Note that the matrix network is engaged in the cytoplasmic conformation and so affects the 
chemical potential of the cytosolic conformation, and vice versa. This form of parameterization 
allows the conformation changes to be modelled with only four parameters: ΔEM, ΔEC and ΔEB and 
kc, and the complete model with only a further two parameters, 
s
fk  and 
s
rk , which are the forward 
and reverse rate constants for substrate binding. 
The forward rate for substrate binding was assumed to be first order in substrate concentration such 
that the substrate binding energy is given by: 
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Equation 5 
where sdK  is the disassociation constants for substrate, s, in the absence of induced-fit binding and 
0
BG  is the standard change in free energy of binding. 
To obtain parameters for the model, experimental data for the mitochondrial ADP/ATP carrier of 
the thermophilic fungus Myceliophthora thermophile were used [21]. In brief, the carrier was 
expressed in Lactococcus lactis without the his-tag, membranes were fused with liposomes and 
transport parameters determined by uptake of 
14
C-labelled ADP [21]. The measured kcat of the wild 
type carrier was approximately 40 ADP/s (table S1). The substrate binding rates are expected to be 
much faster than the transport rates [24] and molecular dynamics simulations report that ADP binds 
in ≈40ns [15] hence the forward rate was set to 25 ns−1M−1 giving a mean binding time of 40ns at a 
concentration of 1mM. A Kd of 40 μM was chosen so that the modelled KM of transport matched 
the experimentally determined KM of transport for weak cytoplasmic networks (figure 6) and this 
fixed the reverse rate constant to 1000/ms (equation 5). It was found that the transport was almost 
linear with the conformational change rate constant kc, which was set to 5.66 μs
-1
 so that the model 
matched the measured transport rates when ΔEC and ΔEB were −550 mV (figure 6). Simulations 
were carried out either by assembling the chemical master equation and solving it in the steady 
state by matrix inversion, or stochastically using Gillespie’s algorithm [29] using software 
compiled with Delphi 2010 (Embarcadero Technologies). 
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9 
Results 
The breaking and formation of the bonds of the 
cytoplasmic and matrix networks produce an 
energy barrier to prevent the carrier switching 
between matrix and cytoplasmic conformations 
in the absence of substrate binding. The ability 
of this energy barrier to limit the rate of 
conformational change was explored by running 
simulations in the absence of an imposed 
substrate binding energy when the cytoplasmic 
and matrix network strengths were varied, but 
set equal to one another.  
In order to distinguish between ADP that (1) 
bound from the cytoplasmic side and was 
released on the matrix side, (2) bound from the 
cytoplasmic side and was released to the 
cytoplasmic side, (3) bound from the matrix side 
and was released to the matrix side and (4) 
bound from the matrix side and released on the 
cytoplasmic side, simulations were carried out 
with “labelled” and “unlabelled” ADP, with both 
having identical rate constants. 
In line with thermodynamics principles, there is 
no net transport of ADP in the steady state when 
substrate concentrations were set to 5mM of 
labelled ADP on the cytoplasmic side and 5mM 
of unlabelled ADP on the matrix side so that the 
influx of labelled ADP can be used as a metric of 
transport. Figure 3 shows that the imposition of 
equal cytoplasmic and matrix network energies, 
in the absence of substrate binding energy, 
effectively impedes transport. As a consequence, 
the residual transport decreases approximately 
exponentially with increasing strength of the 
networks. Thus strong networks will prevent 
changes from matrix to cytoplasmic 
conformation in the absence of a substrate 
binding energy, that is, in the absence of bound 
substrate. 
 
Figure 3. Transport (JT) as a function of the network 
strength in the absence of a substrate binding energy. 
Simulations were carried out with 5 mM of labelled ADP 
on the cytoplasmic side and 5 mM of unlabelled ADP on 
the matrix side with the efflux of unlabelled ADP plotted 
as the cytoplasmic and matrix network strengths were 
varied equally (ΔEC = ΔEM = ΔEM/C). The inset shows 
representative energy profiles. JF is an estimation of the 
limiting forward rate calculated with a simple model (see 
Discussion). 
 
Figure 4. The dependence of transport on the substrate 
binding energy. a) Transport for different symmetric 
network strengths (ΔEM = ΔEC = ΔEM/C) as a function of 
substrate binding energy. Simulations were carried out 
with 5mM of labeled ADP on the cytoplasmic side and 
5mM ADP on the matrix side and the efflux of ADP 
plotted as the substrate binding energy was varied at 
constant symmetric network strength (ΔEM/C). Black line: 
ΔEM/C=−550 mV, grey lines ΔEM/C=−200, −300, −400, 
−500, −600 and −700 mV. The insert shows energy 
profiles for ΔEM/C=−550 mV. b) The chemical potential of 
the intermediate state (μI) at maximum transport rate 
plotted for a given network strength. C) Energy profiles at 
maximum transport rate for different ΔEM/C. 
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10 
The ability of substrate binding to facilitate 
exchange was examined by running the same 
simulations with an equal cytoplasmic and 
matrix network strength of −550 mV and by 
varying the substrate binding energy (black line 
figure 4a). It was found that maximum transport 
occurred when the substrate binding energy was 
approximately equal to the network strength, as 
previously proposed [12]. To explore the 
relationship between the substrate binding 
energy and network strength further, similar 
simulations were carried out with a range of 
equal network strengths from −200 to −700 mV 
(grey lines figure 4a) where it was found that 
maximum transport occurred when the chemical 
potential of the intermediate state was 
approximately equal to the cytoplasmic and 
matrix network strength (figure 4b and 4c). 
Weak networks lead to faster rates of transport 
(see figure S2 in the supplementary data) but 
when the rate constant for the conformational 
change (kc in equation 3) was set so that the 
maximum transport rate for each network 
strength was equal (kc of 0.065, 0.200, 0.721, 
2.810, 11.488 and 48.76 /μs for network 
strengths of −200, −300, −400, −500, −600 and 
−700mV, respectively), the relationship between 
transport rate and substrate binding energy was 
independent of the absolute network strength, 
albeit mildly dependent when ΔES − ΔEM/C > 0 
(grey lines, figure 4a). Importantly, however, the 
maximum transport rate was strongly dependent 
on the difference between the substrate binding 
energy and the network strength (figure 4a). 
The dependence of transport on cytoplasmic 
network strength was determined by running simulations with varying cytoplasmic network 
strength when the matrix network and the substrate binding energy (ΔEM/S) was set to −550 mV 
(figure 5a, black line). It was found that maximum transport occurred when the cytoplasmic 
network strength was very similar to that of the matrix network. Carrying out simulations with a 
range of matrix network strengths, with equal substrate binding energy (figure 5a, grey lines), 
demonstrated that this property was a general feature of the model and that maximal flux occurred 
when the strength of the cytoplasmic network was 5-10 mV above that of the matrix network 
(figure 5b). When the rate constant for the conformational change (kc) was varied such that the 
maximum transport rate was normalized to that of the measured rate, then the dependence on 
transport rate on relative cytoplasmic network strength was similar (figure 5a).  
The KM and kcat for transport from the cytoplasmic and matrix sides were determined by carrying 
out simulations when the substrate concentration was varied between 0 and 100 μM in 0.1 μM steps 
with substrate in the other compartment set to 5 mM. The transport of ADP at different substrate 
concentrations was then fitted to a Michaelis-Menten function using Levenberg-Marquardt non-
linear minimization algorithm to determine the KM and kcat. The results of simulations when the 
matrix network strength and substrate binding energy were set to −550 mV are shown in figure 6 as 
 
Figure 5. The dependence of transport on the cytoplasmic 
network strength. a) Transport for different cytoplasmic 
network strengths (ΔEC) when the matrix network (ΔEM) 
and substrate binding energy (ΔES) are equal (ΔEM/S). 
Simulations were carried out with 5 mM of labeled ADP 
on the cytoplasmic side and 5mM ADP on the matrix side 
and the efflux of ADP plotted as the matrix network 
strength was varied. Black line: ΔEM/S = −550 mV, grey 
lines ΔEM/S = −200, −300, −400, −500, −600 and −700 
mV. The insert shows energy profiles for ΔEM/S = −550 
mV. b) The cytoplasmic network strength at maximum 
transport rate plotted for a given matrix network/substrate 
binding energy. C) Energy profiles at maximum transport 
rate for different ΔEM/S. 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
 
 
11 
a function of the cytoplasmic network strength. 
As expected, the kcat for transport was the same 
for both cytoplasmic and matrix substrate and 
the maximum transport was found when the 
cytoplasmic network, the matrix network and the 
substrate binding energy were all approximately 
equal (ΔEC=−550 mV in figure 6a). The KM for 
cytoplasmic and matrix substrate were also equal 
under these conditions (cf. red and blue circles at 
−550 mV, figure 6b), which would be expected 
because the model is symmetric about the 
intermediate conformation when the cytoplasmic 
and matrix networks have equal strength. This 
symmetry is broken when the networks have 
unequal strength and a strong cytoplasmic 
network resulted in a submicromolar KM from 
the cytoplasmic side whereas the KM from the 
matrix side approached the Kd (40 μM). With a 
weak cytoplasmic network, the KM from the 
cytoplasmic side was 12-14 μM, whereas the KM 
from the matrix side was submicromolar. 
Figure 6 compares the kcat and KM of the model 
with those determined experimentally using 
vesicles fused with L. lactis membranes 
expressing wild type or mutant carriers [21]. The 
carrier protein in the membrane-vesicle fusions 
was estimated to be 90% orientated with their 
cytoplasmic side on the outside of the vesicle by 
their ability to be inhibited by membrane-
impermeable carboxyatractyloside, which only 
inhibits from the cytoplasmic side. The vesicles 
were loaded with 5 mM ADP and the initial rate, 
calculated from the linear part of the 
14
C-ADP 
uptake curve for different external 
14
C-ADP 
concentrations, was fitted to a Michaelis-Menten 
function as previously described. The apparent 
kcat and KM values for the experimental 
cytoplasmic substrate are shown in Figure 6 as a 
function of network strength. The experimental 
and modelled data was registered visually where 
the cytoplasmic network strength in millivolts 
was estimated to be ≈−130N−240 where N is the network interaction energy in number of salt 
bridges. 
We have previously suggested that differences in the network strengths would allow the carrier to 
act as a uniporter rather than an exchanger with the rationale that there would be a higher 
probability that a weak network would break in the absence of substrate [12]. To test this 
possibility, simulations were carried out under different substrate gradients when the matrix 
network strength and substrate binding energy were set to −550 mV and the strength of cytoplasmic 
network was varied (figure 7). As expected, the carrier acted as an exchanger when 5 mM of 
labelled and unlabelled substrate was available on opposite sides of the membrane (black line). 
Very little uniport efflux was observed when substrate was only present on the matrix side, 
 
Figure 6. Experimental and modelled kcat and KM for 
transport of cytoplasmic (Cyt) and matrix (Mat) substrate. 
The modelled points were calculated by performing 
simulations with ΔEM and ΔES set to −550 mV with 
different substrate concentrations in either the 
cytoplasmic or matrix compartments (with the substrate in 
the other compartment set to 5 mM), and then fitting the 
rate of transport to a Michaelis-Menten function. To 
prevent overlay, only alternate points of cytoplasmic and 
matrix modelled kcat were plotted. The experimental 
values are from the uptake of 
14
C ADP into membrane-
fused vesicles when the internal ADP was at 5 mM. The 
relationship between network strength in salt bridges 
(experimental data, top x axis) was registered visually 
with the network strength in millivolts (modelled data, 
bottom x axis). The lines in a) are from a simplified 
model described in the supplementary information and the 
lines in b) from a simplified model described in the 
Discussion.  
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12 
regardless of the cytoplasmic network strength 
(red line). On the other hand, substantial uniport 
influx did occur when 5 mM substrate was present 
only on the cytoplasmic side and when the 
strength of the cytoplasmic network was weaker 
than that of the matrix network (blue line). The 
maximum uniport transport occurred when the 
cytoplasmic network was ≈−330 mV, equivalent 
to ≈0.7 salt bridges when using the comparison 
introduced in figure 6. However, this uniport 
influx was an order of magnitude lower than the 
exchange rate when the networks were of equal 
strength. 
Many studies on reconstituted carriers are carried 
out under idealised conditions with substrate 
present on only one side of the membrane for 
uniporters or different substrates present on each 
side of the membrane for exchange (e.g. ATP and 
ADP or labelled and unlabelled ADP for the 
ADP/ATP carrier). This may not be the case for 
carriers operating under physiological conditions 
if the downstream enzymes do not further 
metabolize the substrate sufficiently. In order to test whether returning to the cytoplasmic 
conformation with or without substrate would affect net uniport activity, simulations were carried 
out when 5 mM of substrate was present on the cytoplasmic side and 0.2 mM of substrate was 
present on the matrix side. Under these conditions the carrier both exported and imported substrate. 
It was found that net substrate influx, which is the uniport component of transport, was almost 
abolished (Figure 7, green line), although the carrier exchanged substrates at high rates determined 
by the KM on the matrix side. This result indicates that a carrier with a weak cytoplasmic network 
would not function well as a uniporter under conditions where substrate was present on both sides 
of the membrane. 
 
Figure 7. The dependence of exchange and uniport 
activity on the cytoplasmic network strength. Simulations 
were carried out with ΔEM=ΔES= −550 mV and the 
graphics show the substrate concentration on each side of 
the membrane. 
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Discussion 
Our model was able to reproduce the dependency of both kcat and KM on the cytoplasmic salt bridge 
network strength (figure 6) with good quantitative accuracy and with very few free parameters 
implying that the model captures the essence of the transport mechanism and provides a framework 
to understand the structure-function relationships of this class of transporters. The model confirms 
that the cytoplasmic and matrix networks not only close access of the binding site to the respective 
compartments but also provide the free energy barrier that prevents conformational changes in the 
absence of substrate. 
In the steady state, the transport rate, JT, is equal to the net flux of a substrate through any of 
neighbouring confirmations, 
scsc
nJ
,1, 
, and is given by: 
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Equation 7 
where scscJ ,1,   and scscJ ,,1   are the forward and reverse fluxes, scP ,  and scP ,1  are the probability 
that the carrier is found in the neighbouring conformations c and c+1, respectively, with substrate s 
bound, and scsck ,1,   and scsck ,,1   are the forward and reverse rate constants, respectively, for the 
conformational change. In our model of the carrier as a nanomachine, transport is not limited by the 
rate constants, which are five orders of magnitude greater than the kcat of transport. Instead, it is the 
very low probability of attaining the highest energy states that limit the forward and reverse fluxes, 
and hence the net flux. 
In the absence of a substrate binding energy (conditions of figure 3a), the probability distribution of 
the carrier conformation will reach thermal equilibrium in the steady state and be governed by 
Boltzmann’s distribution (see S.1 in the supplementary information for a proof) such that the 
probability cP  that the carrier is in conformation c will be given by: 
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Equation 8 
where the denominator is the partition function. The forward flux is then given by 
scsc
fcsc
scsc
f kPFJ
,1,
,
,1,    where scF ,  is the fraction of carriers in conformation c that have 
substrate s bound. While the conformation is in close thermal equilibrium, the states of the model 
are not in equilibrium because there is a gradient in the fraction of substrate bound at different 
conformations (figure S.1 of the supplementary data) and this gradient allows net transport to 
occur.  
The conformation with the smallest forward flux is the intermediate conformation (c=0) because it 
has the highest chemical potential and hence the numerator of equation 8 is smallest. The 
denominator is dominated by the matrix and cytoplasmic conformations (most left and most right 
terms) because they have the lowest chemical potential. The probability of the carrier being in the 
intermediate state PI is approximated by 
  Tk
I
BNIeP
00
½
 
  where 0I  and 
0
N  are the standard 
chemical potentials of the intermediate and cytoplasmic/matrix conformation, respectively, and the 
factor ½ accounts for both the cytoplasmic and matrix terms appearing in the denominator of 
equation 8. Thus the difference in chemical potential between the cytoplasmic/matrix conformation 
and the intermediate conformation represents an energy barrier that results in a low probability of 
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the carrier reaching the intermediate conformation. This analysis is confirmed when the forward 
flux, calculated with equation 8 and assuming the fraction of bound labelled ADP is 0.5, is 
compared to the transport rates (figure 3) where it is found that the forward flux is only 60% larger 
than the net flux at high network strengths. This simple analysis of barrier height dictating transport 
rate is verified when the net flux is estimated (see S.4 in the supplementary data), whereupon the 
barrier is dependent on the mean chemical potential of the highest energy neighbouring 
conformations rather than simply the highest energy conformation. 
The previous analysis is still a good 
approximation if a substrate binding energy is 
non-zero as long as the concentration of 
substrate on both sides of the carrier is high, 
ensuring the probability of unbound carrier is 
near zero. In this case, the energy levels refer to 
the carrier with bound substrate.  
With the imposition of a substrate binding 
energy, the conformation with minimum 
probability shifts from the intermediate 
conformation to the two maxima with equal 
chemical potential between the intermediate 
conformation and the cytoplasmic and matrix 
conformations (figure 8a, red trace). Under these 
conditions the energy profile has two maxima 
and two minima. Similar to the presence of two 
minimum energy states (cytoplasmic and matrix) 
doubling the denominator of equation 8 and 
halving the transport rate, the effect of two equal 
maxima is also to halve the transport rate 
compared to one maximum (see supplementary 
data S.5). Furthermore, a rigorous analysis shows that the maximum of the energy barrier is an 
average of all the states exponentially weighted to the high energy states and that the minimum of 
the energy barrier is also an average but exponentially weighted to the low energy states 
(supplementary data S.5). Because the weighting is exponential, the barrier maximum and 
minimum is dominated by the high and low energy states, respectively, the energy barrier can be 
estimated simply from the difference between the maximum and minimum of the energy profile 
(figure 8a, red arrow). Increasing the substrate binding energy initially reduces the energy barrier 
(figure 8a green arrow) as the maximum is decreased until the standard chemical potential of the 
intermediate state falls below the cytoplasmic and matrix conformations whereupon the energy 
barrier, which is now between the intermediate state and the two maxima, increases with increasing 
substrate binding energy (figure 8a, blue arrow). The transport rate therefore increases with 
increasing substrate binding energy up to a maximum when the chemical potential of the 
intermediate conformation is approximately equal to that of the cytoplasmic and matrix 
conformation, whereupon the energy barrier is at a minimum, and then decreases with further 
increases in substrate binding energy. This analysis shows that the energy barrier is not an 
activation energy, which would be defined as the difference between the cytoplasmic and energy 
maximum between the cytoplasmic and intermediate conformations and would determine the rate 
constant for the conformational change between the cytoplasmic and intermediate conformation, 
but is rather the difference between energy maximum and energy minimum that sets the probability 
of being in the high energy conformation and hence determines the flux.  
Similarly, when the cytoplasmic network is weaker than the matrix network, the matrix maximum 
rises in energy and the energy barrier, which is between the cytoplasmic conformation and the 
matrix maximum, increases (figure 8b red trace, red arrow) decreasing the transport rate (figure 5a). 
 
Figure 8. Energy profiles and transport energy barriers 
shown as arrows between the lowest energy state(s) and 
the highest energy state(s). a) symmetric network strength 
of −550 mV with substrate binding energies of −400, 
−550 and −700 mV. b) A matrix and substrate binding 
energy of −550 mV with a cytoplasmic network of −400, 
−550 and −700 mV. 
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In contrast, when the cytoplasmic network is stronger than the matrix network, the chemical 
potential of the matrix maximum and matrix conformation is lowered such that the energy barrier, 
which is now between the cytoplasmic maximum and matrix conformation, increases (figure 8b 
blue trace, blue arrow) decreasing the transport rate. The minimum energy barrier occurs when the 
cytoplasmic network is equal in strength to the matrix network and the substrate binding energy 
whereupon the transport rate is a maximum. The similarity in the dependence of energy barrier on 
substrate binding energy and on the cytoplasmic network strength (figure 8a and 8b, respectively) 
explains the similarity of the dependence of transport on substrate binding energy and on the 
cytoplasmic network strength (figure 4a and 5a, respectively). 
At non-saturating substrate concentrations, the probability of the carrier without substrate bound 
becomes significant and these states must be included in the partition function. The rate of substrate 
binding and release is much faster than transport [24] so that the unbound cytoplasmic and matrix 
conformation will be maintained in close equilibrium with the corresponding substrate-bound 
conformation. With these approximations, equation 8 can be rewritten 
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Equation 9 
where the denominator is the partition function, [ADPc] and [ADPm] are the concentrations of ADP 
on the cytoplasmic and matrix side, respectively, Zs are the terms of the partition function of the 
substrate-bound carrier shown in the denominator of equation 8, and Zc and Zm are the terms of the 
partition function for the unbound carrier on the cytoplasmic and matrix side, respectively (see 
figure 9). The factors ][ cd ADPK  and ][ md ADPK  
account for the ΔEB of substrate binding such that Zc 
and Zm are independent of substrate concentration 
(see S.3 of the supplementary information). Note 
that equation 9 tends to equation 8 when the 
substrate concentrations are very large. From this, 
the KM for transport on the cytoplasmic and matrix 
side, cMK  and 
m
MK , respectively, are given by: 
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Equation 10 
and plotted as the lines in figure 5 showing an 
excellent agreement between this approximation and 
the full model.  
When the cytoplasmic and matrix networks are 
equal strength then mc ZZ   and the KM’s are equal. 
Weakening the cytoplasmic network (figure 9a and 
b) decreases Zs by a maximum factor of 2 as the 
right hand terms of the denominator vanish. Zc is 
independent of the cytoplasmic network strength so 
the KM on the cytoplasmic side increases by a 
maximum of a factor of 2. Zm strongly decreases 
 
Figure 9. The partition function for the carrier with 
ΔEM = ΔES = −550 mV and ΔEC = −400mV, −550 
and −700 mV for the upper middle and lower graphs, 
respectively. a), c) and e) States contributing to the 
unbound cytoplasmic (Zc), unbound matrix (Zm) and 
substrate bound (Zs) partial partition functions. b), d) 
and f) Normalized Boltzmann coefficients (Pc). 
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with weakening of the cytoplasmic network and hence the KM on the matrix side decreases to near 
zero. Strengthening the cytoplasmic network strongly increases Zs and Zm while decreasing Zc and 
the KM on the cytoplasmic side decreases to near zero. 
The model clearly predicts that the maximum transport occurs when the interaction energies of the 
cytoplasmic network, matrix network and substrate binding are approximately equal such that the 
energy barrier is a minimum. The wild type carrier has a matrix network of three salt bridges 
braced by a hydrogen bond from a glutamine residue [9]. In the semi-quantitative measure 
introduced before in which a hydrogen bond has half the strength of a salt bridge, this extra 
interaction would give the matrix network a total strength of 3.5 salt bridges. The phosphate groups 
of ADP may form salt bridges with the three positively charged residues of the binding site and the 
adenine ring may form a π-stacking arrangement with a tyrosine residue [5, 10, 12, 14-15] thus 
giving the substrate binding energy a total strength of 3.5, similar to that of the matrix network. 
This equal strength between the network and the substrate binding energy is predicted by the model 
to give maximum kcat. The cytoplasmic network of the fungal ADP/ATP carrier consists of two salt 
bridges and a hydrogen bond giving it a total strength of 2.5. It would therefore be predicted that 
mutating the hydrogen bond of the cytoplasmic network to a salt bridge would increase the kcat 
compared to the wild type. Unexpectedly, the kcat of this mutant is actually decreased and the 
carrier with the greatest kcat is the mutant with a cytoplasmic network strength 0.5 salt bridges 
weaker (figure 6 and table S.1) indicating that the combined interaction energy of the wild type 
carrier in the matrix conformation must be approximately half a salt bridge greater than in the 
cytoplasmic conformation. Further experimental evidence for this is that the KM for transport is 
larger from the matrix (25 μM) than the cytosol (10 μM) [30], as would be predicted by the model 
for a stronger cytoplasmic network (figure 6). Simply counting the number of salt bridges and 
hydrogen bonds is a coarse form of quantitation and the free energy of formation of the bond will 
depend on the bond length and unfavourable desolvation that must occur to form a salt bridge [31] 
but this work predicts that there must be additional interactions involved in the stabilisation of the 
matrix conformation with a strength equivalent to 1.5 salt bridge interactions. There is a highly 
conserved symmetrical motif [FW]xx[YF] present at the cytoplasmic side of the carrier [9, 32-33]. 
These aromatic residues could be involved in multiple aromatic stacking arrangements, each 
approximately equivalent to a hydrogen bond, which could increase the overall interaction energy 
of the matrix conformation. Confirmation of this hypothesis will have to await a crystal structure of 
the carrier in the matrix conformation.  
A recent paper has attempted to map out the free energy landscape of the carrier conformation 
change using well-tempered metadynamics [34]. The authors have calculated that the cytoplasmic 
and matrix conformations are separated by an energy barrier of ≈430 mV (10 Kcal/mol) in the 
absence of substrate, which would robustly prevent leak (figure 1). Our analysis would predict that 
maximum transport would occur with a ΔES of ≈400mV which would lower the energy barrier by 
≈230mV. Binding of ADP generated a minimum in the free energy landscape ≈260 mV below the 
energy barrier in the absence of substrate [34], but this minimum was offset from the conformation 
with maximum energy and only lowered the energy barrier by ≈86 mV. Our interpretation of the 
modelling concludes that it is the lowering of the energy barrier, and not the presence of an energy 
minimum, that allows substrate transport. Lowering the barrier by only 86 mV would not produce 
rapid transport compared to the 230 mV predicted by our model for maximum transport (figure 4c). 
Furthermore, binding of ATP did not generate a significant energy minimum in the intermediate 
conformation compared to the empty carrier, or lower the energy barrier, suggesting that the 
binding energy of ATP did not increase in the intermediate conformations. The failure of substrate 
to lower the energy barrier substantially in the metadynamics simulations could be caused by 
carrying out insufficient iterations for the simulation to fully probe state space and find those states 
in which the substrate is tightly bound before the applied potential drives the conformational 
changes further. Moreover, the structures in the simulations are not consistent with an alternating 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
 
 
17 
access mechanism, as there is no substrate-occluded intermediate state or a closed matrix state 
involving the formation of the cytoplasmic network, as experimentally shown [9, 21]. 
The mitochondrial carrier family, in which the matrix and cytoplasmic networks are common 
motifs, include both exchangers and uniporters. The modelling shows that very unequal network 
strengths can lead to unidirectional uniport activity in the direction from weak to strong network 
(figure 7), because the energy barrier for breaking a weak network in the absence of substrate is 
sufficiently small that the carrier can return to the conformation with the strong network engaged 
without bound substrate. However, the cost of reducing the return energy barrier is that the forward 
energy barrier is larger, even in the presence of substrate (figure 8a), and hence transport rates are 
slower. Furthermore, the energy barrier for return is always smaller when substrate is bound than 
when not bound such that return with substrate is preferred and there is negligible uniport activity 
when substrate is present on both sides of the membrane (figure 7). For a mitochondrial carrier that 
imports substrate, such as the glutamate carrier that imports glutamate into the matrix where 
glutamate dehydrogenase is exclusively located [35], or the inorganic phosphate carrier that imports 
phosphate into the matrix for conversion with ADP to ATP by the ATP synthase, this would 
require a weak cytoplasmic network and a low concentration of substrate in the matrix. Both 
transporters carry out substrate transport in symport with a proton (or antiport with a hydroxyl ion) 
such that the net transport is electroneutral. The substrate binding site of the phosphate carrier 
contains positively charged residues, which could form salt bridges to the phosphate, and a 
glutamate residue that could aid proton binding for symport [12]. Likewise, the glutamate carrier 
also contains a glutamate in the binding site suggesting it too symports a proton [12]. Symport 
would require that the two substrates bind co-operatively, that is, the Kd of binding one substrate is 
much lower when the other substrate is already bound, so that the probability of only having one 
substrate bound is very low. The glutamate carrier has a matrix network of three salt bridges and a 
cytoplasmic network lacking any salt bridges or hydrogen bonds [12] with a very low kcat for homo 
exchange (0.083 and 0.019 /s for isoform 1 and 2, respectively [35]) suggesting that it achieves 
uniport activity by unequal network strengths, consistent with the findings of our modelling. The 
uniport activity is 10-30% of the homo exchange [35] but the net uniport activity in the presence of 
internal glutamate has not been measured. In contrast, the phosphate carrier has equal 
mitochondrial and cytoplasmic networks, consisting of two salt bridges [12] and has higher activity 
than the ADP/ATP carrier [30]. The relatively weaker network strength would explain the higher 
activity for homo-exchange compared to the ADP/ATP carrier but the uniport activity should be 
vanishingly small whereas it has been measured to be similar to exchange activity [36]. 
Furthermore, the phosphate uniport action is bidirectional (uniport can occur in both directions) 
[37] whereas a strong/weak network combination would be expected to generate only 
unidirectional transport. Together, this would suggest that the phosphate carrier employs an 
alternative mechanism to substitute for the substrate binding energy during the change between 
conformations when substrate is not bound.  
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